1. Marwaha S, Knowles JW, and Ashley EA. Genome Med. 2022 Feb 28;14(1):23. doi: 10.1186/s13073-022-01026-w. 2. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014 Dec 3;6(265):265ra168. doi: 10.1126/scitranslmed.3010076. 3. Lunke S, Bouffler SE, Patel CV et al. Nat Med. 2023 Jun 8. 4. Maron JL, Kingsmore S, Gelb BD, et al. JAMA. 2023 Jul 11;330(2):161-169. 5. Dimmock D, Caylor S, Waldman B, et al. Am J Hum Genet. 2021 Jul 1;108(7):1231-1238. 6. Manickam K, McClain MR, Demmer LA et. al; ACMG Board of Directors. Genet Med. 2021 Nov;23(11):2029-2037. 7. Sheidley BR, Malinowski J, Bergner AL, et al. Epilepsia. 2022 Feb;63(2):375-387. 8. Lewis SA, Ruttenberg A, Iyiyol T, et al. EBioMedicine. 2024 Aug;106:105229. 9. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421. 10. Chen E, Facio FM, Aradhya KW, R, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2339571. 11. Savatt JM, Myers SM. Front Pediatr. 2021 Feb 19;9:526779. 12. Majewski J, Schwartzentruber J, Lalonde E, et al. What can exome sequencing do for you? J Med Genet. 2011 Sep;48(9):580-9. doi: 10.1136/jmedgenet-2011-100223.
Â
*Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
